Camrelizumab Combined With Gemcitabine and Albumin-Bound Paclitaxel for Neoadjuvant Therapy in the Treatment of Progressive Gallbladder Cancer: A Case Report

BACKGROUND: The roles of immune checkpoint inhibitors in the treatment of gallbladder cancer are still unclear and challenged by controversial findings. Recent research has shown that immune checkpoint inhibitors in combination with chemotherapy may alleviate disease progression. CASE SUMMARY: A 45-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jing, Wang, Zheng, Li, Jing, Peng, Xue-Hui, Tang, Yi-Chen, Huang, Xiao-Bing, He, Yong-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967141/
https://www.ncbi.nlm.nih.gov/pubmed/35372051
http://dx.doi.org/10.3389/fonc.2022.818626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967141/
https://www.ncbi.nlm.nih.gov/pubmed/35372051
http://dx.doi.org/10.3389/fonc.2022.818626

Ejemplares similares